Samuel Wilkinson
3 presentations
-
CONDUCTING CLINICAL TRIALS USING COMBINED TREATMENT MODALITIES: CHALLENGES, OPPORTUNITIES, AND INSIGHTS FOR FUTURE REGULATORY CONSIDERATION
-
COGNITIVE BEHAVIORAL THERAPY FOLLOWING ESKETAMINE FOR MAJOR DEPRESSION AND SUICIDAL IDEATION FOR RELAPSE PREVENTION: THE CBT-ENDURE STUDY
-
KETAMINE FOR DEPRESSION, BUT AT WHAT COST? EVIDENCE FOR NEUROTOXICITY FROM HUMAN AND ANIMAL STUDIES